Literature DB >> 28905850

Erratum: A cross-sectional study to compare intraocular pressure measurement by sequential use of Goldman applanation tonometry, dynamic contour tonometry, ocular response analyzer, and Corvis ST.

.   

Abstract

[This corrects the article DOI: 10.4103/0301-4738.171956.].

Entities:  

Year:  2017        PMID: 28905850      PMCID: PMC5621289          DOI: 10.4103/0301-4738.214668

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


In the article titled “A cross-sectional study to compare intraocular pressure measurement by sequential use of Goldman applanation tonometry, dynamic contour tonometry, ocular response analyzer, and Corvis ST”, published in the pages 815-820, issue 11, vol. 63 of Indian Journal of Ophthalmology[1], the name of the fourth author in the “Cite this article as” is written incorrectly as “Roy AS” instead of “Sinha Roy A”. The “Cite this article as” section should read as “Tejwani S, Dinakaran S, Joshi A, Shetty R, Sinha Roy A. A cross-sectional study to compare intraocular pressure measurement by sequential use of Goldman applanation tonometry, dynamic contour tonometry, ocular response analyzer, and Corvis ST. Indian J Ophthalmol 2015;63:815-20.”
  1 in total

1.  A cross-sectional study to compare intraocular pressure measurement by sequential use of Goldman applanation tonometry, dynamic contour tonometry, ocular response analyzer, and Corvis ST.

Authors:  Sushma Tejwani; Shoruba Dinakaran; Anuja Joshi; Rohit Shetty; Abhijit Sinha Roy
Journal:  Indian J Ophthalmol       Date:  2015-11       Impact factor: 1.848

  1 in total
  1 in total

1.  Comparison among Ocular Response Analyzer, Corvis ST and Goldmann applanation tonometry in healthy children.

Authors:  Ramin Salouti; Ali Agha Alishiri; Reza Gharebaghi; Mostafa Naderi; Khosrow Jadidi; Ahmad Shojaei-Baghini; Mohammadreza Talebnejad; Zahra Nasiri; Seyedmorteza Hosseini; Fatemeh Heidary
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.